SBIR/STTR Research Award
Standardization of HER-2/neu Tests
Award amount
$99,995Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- CELL CONTROL SCIENCES, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Applicant's abstract): Breast cancer is one of the greatest
threats to the health and well being of every woman. The detection, diagnosis,
and treatment of this cancer is a major initiative in the United States.
HER-2/neu overexpression is associated with breast cancer prognosis and
response to chemotherapy or endocrine therapy. Her-2/neu
overexpression/amplification can be assessed by different techniques, including
immunohistochemistry, fluorescence in situ hybridization (FISH), and various
genetic hybridizations.
However, the assessment of this important prognostic maker is hampered by the
lack of standardization of the various methodologies, scoring systems, and
widely accepted controls. Moreover, there is no general data bank where the
laboratories can post their results for either comparison with other
laboratories or evaluation of self-performance. We suggest that, if uniform,
cell culture-based control slides were used by individual laboratories, this
would ensure proper quality control over time and allow correlation of results
with other laboratories. Potentially such controls could be used as standards
and calibrators for quantitative immunohistochemistry, fluorescence in situ
hybridization, and various genetic hybridization procedures. The specific aims
of this proposal are : 1) To prepare cell culture-based controls for
immunohistochemical detection of Her-2/neu protein; 2) To prepare cell
culture-based controls for fluorescence in situ hybridization (FISH) analysis
of the Her-2/neu oncogene; 3) To prepare cell culture-based controls for
polymerase chain reaction (PCR), Southern blots, Northern blots, and Western
blot hybridization analysis of the Her-2/neu oncogene.
PROPOSED COMMERCIAL APPLICATIONS:
Uniform and replenishable control slides prepared from cultured cells can be marketed as standards and calibrators for quantitative immunohistochemistry, fluorescence in situ hybridization, and various genetic hybridizations in diagnostic laboratories around the world. These controls ensure proper quality control over time and to allow correlation of results among multiple laboratories.
Technology keywords
Not reported